NPC
RPTP

National Planning Corporation’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

National Planning Corporation’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-500
Closed -$5.31K – 2794
2014
Q4 		$5.31K Buy
+500
New +$4.89K ﹤0.01% 2293

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

National Planning Corporation's RPTP Position: Q1 2015 in Review

National Planning Corporation sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2015, closing a stake of 500 shares — an estimated $5.31K sold.

National Planning Corporation first reported a position in RPTP in Q4 2014 and held it in 1 quarter. The position peaked at $5.31K in Q4 2014. 75 funds tracked by Wall St. Rank hold RPTP as of Q1 2015.

  • National Planning Corporation reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 500 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2015, an estimated $5.31K.
  • National Planning Corporation first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $5.31K in Q4 2014.
  • 75 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.